GUK Antibodies

Santa Cruz Biotechnology features a diverse variety of GUK Antibodies for studying guanylate kinases, which play a crucial role in cellular signaling and the regulation of various physiological processes. GUK monoclonal antibodies enable multiple research applications including western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). Guanylate kinases are essential for the synthesis of cyclic GMP, a key secondary messenger involved in numerous signaling pathways, including those regulating vascular tone, neurotransmission, and cell proliferation. The proper functioning of guanylate kinases is vital for maintaining cellular homeostasis and responding to external stimuli. Dysregulation of guanylate kinases has been implicated in various diseases, making them important targets for therapeutic intervention. Understanding guanylate kinase activity and regulation can provide valuable insights into disease mechanisms and potential treatment strategies. Research utilizing GUK monoclonal antibodies may reveal new therapeutic targets and biomarkers. Investigating guanylate kinase function contributes to our understanding of fundamental cellular processes. Santa Cruz Biotechnology monoclonal antibodies for GUK research support scientists worldwide in advancing our understanding of cellular signaling pathways and disease mechanisms.